Innovia Medical is proud of the addition of the DTR Medical® Oral Rotating Biopsy Punch to their Single-use ENT range!
BIOHIT HealthCare is pleased to extend its corporate partnership with the British Laryngological Association (BLA) for a second year running, supporting its pursuit of improved diagnosis for laryngopharyngeal reflux (LPR).
HIMSA is happy to announce that due to a successful 2023, we are now able to offer significant price reductions on a Noah ES yearly subscription.
Soluvos Medical is proud to announce that their partnership with A.R.C. Laser has now extended to the UK. They have a full team in the UK, available for advice, hires, service and training.
BHM offers comfortable, tried-and-tested hearing solutions with its bone conduction hearing systems.
While corticosteroids are widely used to treat Sudden Sensorineural Hearing Loss (SSNHL), there is still no therapy with proven efficacy and regulatory approval for this debilitating condition.
Up to 500,000 GP appointments could be saved per annum with patient self-referral to audiology practices - easing pressure on the NHS, according to a new report.
For more than a century, hearing aids have been prescribed based solely on the pure tone audiogram.With the introduction of ACT, Interacoustics goes beyond the audiogram, and is now able to address the number one complaint from people with hearing loss: hearing conversations in noisy situations.
BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.
Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.
Entermed’s budget-friendly Micronomic III is a compact workstation designed to accommodate every ENT surgeons’ basic requirements in tight conditions.
Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.